Objects Clause And Exclusion From Patentability – Are Biotech Related Patents Under Attack In Australia?

by FPA Patent Attorneys

The Australian Patent Office has released a consultation paper which seeks public comment on the proposed amendments to the Australian Patents Act 1990 (‘the Act’) to introduce an object clause and a patentability exclusion to prevent the commercialisation of inventions that would be “wholly offensive to the Australian public”.

While both proposed amendments are “technology neutral” in that they do not refer to a specific technology area, it is highly likely that the application of these amendments, particularly the patentability exclusion, will be found on applications and patents in the biotech space.

Patentability exclusion

The current proposal is to exclude from patentable subject matter inventions the commercial exploitation of which would be offensive to the Australian public.

Readers of this article and the consultation paper will no doubt be familiar with provisions in the legal framework of other jurisdictions, such as Europe, Japan and New Zealand, that exclude inventions from patentability based on morality grounds. 

The current proposal is to replace the existing provisions that exclude from patentability inventions that are ‘contrary to law’ with the following exclusion:

… exclusion for an invention the commercial exploitation which would be wholly offensive to the ordinary reasonable and fully informed member of the Australian public.

The reasoning given in the paper for the proposed exclusion is the possible non-compliance with Australia’s obligations under the World Trade Organization Trade Related Aspects of Intellectual Property Rights Agreement (TRIPS) of the existing “contrary to law” exclusion and the inability of the existing provision to address circumstances where there is a lawful use of an invention but where the Australian public object to commercialisation of the invention.

Should the proposal be implement in its current form, only patent applicants during prosecution would be faced with this objection and it could not be used as a ground to oppose the grant of an already accepted application or to revoke a granted patent. The paper acknowledges the difficulty Australian patent examiners will be faced with in implementing these provisions and has called for comment on a proposal to allow the Commissioner of Patents to seek non-binding advice and to decide the most appropriate way to seek the advice.

Biotech in the crosshairs

Equivalent morality-based bars to patentability in other jurisdictions have found most frequent application in the biotech space. In Europe, objections to the patentability of inventions of which “would be contrary to ‘ordre public’ or morality” have been made to inventions including transgenic mice, herbicide resistant plants, nucleic acids encoding for a naturally occurring hormone and various stem cell based technologies. In New Zealand the equivalent “contrary to morality” provision is used to object to the patentability of methods of medical treatment. 

Whether the proposed amendment to the Act will give rise to objections to inventions of similar technology is unclear, however it is unlikely given the Australian Patent Office’s practice of granting patents to transgenic mice, transgenic plants, isolated nucleic acids, certain stem cell based inventions and methods of medical treatment. 

While there does not appear to be a clear mechanism for a third party to object to the patentability of an invention should the Act be amended as proposed, potentially these provisions do provide special interests groups opposed to the patenting of an invention on ethical grounds some way to influence the examination process. Will the Australian Patent Office only raise objections based on the proposed patentability exclusion of their own volition, or will they be influenced by third party correspondence? This is unclear at this stage.

It is worth noting that the specific exclusion is for an invention “the commercial exploitation” of which would be wholly offensive. What this suggests is that invention the creation of which would be wholly offensive should not per se be excluded. For example, consider a hypothetical situation where the Australian public considers use of transgenic mice as wholly offensive. A transgenic mouse model of human cancer is used to identify a small molecule that inhibits cancer metastasis and a patent to this compound is applied for. The proposed provision should not be a bar to the patentability of this compound as the commercial exploitation would involve chemically synthesis of the compound and beneficial medical treatment without any further involvement of the transgenic mouse.

Object clause

In response to a number of reviews into the types of subject matter that should be patentable in Australia, the Australian Government accepted a recommendation to introduce an object clause into the Act. Amending an Act so long after its initial commencement to include a statement as to its purpose might seem odd but the introduction of an object clause, along with the patentability exclusion, appears to be a political compromise between those for and against a legislative change to the test for what is patentable subject matter.

In legislative interpretation an object clause can serve to outline the underlying purposes of the legislation or to set out overall aims and principles that can assist to interpret the provisions of the legislation.

The specific purpose of including an objects clause in the Act is to clarify the interaction between the patents system and competition policy.

Two potential objects clauses are provided in the consultation paper including the following:

…the purpose of the patent system is to provide an environment that enhances the well-being of Australians by promoting innovation and the dissemination of technology and by balancing the competing interests of patent applicants and patent owners, the users of technology, and Australian society as a whole. 

It is unclear how the object clause stated above, or the alternative clause given in the paper, would be used by Australian courts to interpret provisions of the Act. However, it is unlikely that clear statutory language could be varied by such a clause.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© FPA Patent Attorneys | Attorney Advertising

Written by:

FPA Patent Attorneys

FPA Patent Attorneys on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.